We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VistaGen Therapeutics Inc | NASDAQ:VTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 3.17% | 4.55 | 4.26 | 4.56 | 4.55 | 4.31 | 4.47 | 191,064 | 01:00:00 |
NEVADA
|
000-54014
|
20-5093315
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
|
For
|
Withheld
|
||
|
Votes
|
%
Voted
|
Votes
|
%
Voted
|
Jon S.
Saxe
|
3,491,384
|
79.95
%
|
875,575
|
20.05
%
|
Shawn K.
Singh
|
3,607,492
|
82.61
%
|
759,467
|
17.39
%
|
H. Ralph
Snodgrass
|
4,267,739
|
97.73
%
|
99,220
|
2.27
%
|
Brian J. Underdown
|
3,491,384
|
79.95
%
|
875,575
|
20.05
%
|
Jerry
B. Gin
|
4,366,959
|
100.00
%
|
–
|
–
|
|
For
|
Against
|
Abstain
|
Votes
|
3,484,758
|
876,208
|
400
|
%
Voted
|
79.90
%
|
20.09
%
|
0.01
%
|
|
For
|
Against
|
Abstain
|
Votes
|
3,484,502
|
882,057
|
400
|
%
Voted
|
79.79
%
|
20.20
%
|
0.01
%
|
|
Three
Years
|
Two
Years
|
One
Year
|
Abstain
|
Votes
|
3,028,451
|
140,360
|
1,147,822
|
50,326
|
%
Voted
|
69.35
%
|
3.21
%
|
26.28
%
|
1.15
%
|
|
For
|
Against
|
Abstain
|
Votes
|
4,943,389
|
–
|
400
|
%
Voted
|
99.99
%
|
–
|
0.01
%
|
|
VistaGen
Therapeutics, Inc.
|
|
|
|
|
Date:
September 27, 2016
|
By:
|
/s/ Shawn K. Singh
|
|
|
Shawn
K. Singh
Chief
Executive Officer
|
1 Year VistaGen Therapeutics Chart |
1 Month VistaGen Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions